Viemed Healthcare Inc. Common Shares (VMD)

FairStock Score: 70/100 — STEADY

Key Financials

Strengths

• Generates $16 million in annual free cash flow (4.3% yield on market cap)
• Strong Piotroski F-Score of 8/9 indicating robust financial health across profitability, leverage, and efficiency metrics
• Solid return on equity of 11.1% above cost of capital
• Conservative balance sheet with debt-to-equity of just 0.11, providing financial flexibility
• Altman Z-Score of 5.2 confirms minimal bankruptcy risk and strong solvency

Concerns

• Trades significantly above Graham Number ($6) with negative 71% margin of safety—limited downside protection

AI Analysis

Viemed Healthcare Inc. Common Shares is a micro-cap healthcare company valued at $367 million. The business generates $270 million in annual revenue with a 2.1% net margin and $16 million in free cash flow. From a quality standpoint, Viemed shows near-perfect Piotroski F-Score of 8/9 indicating exceptional financial health and Altman Z-Score of 5.2 confirms fortress-level solvency. On valuation, the stock is trading at a premium 25.6x earnings, with trades above its Graham Number with a negative 71% margin. Growth dynamics show revenue growing at 25.5% and profit growth of 30.6%. Our composite FairStock Score of 70/100 reflects above-average fundamentals overall. Investors should weigh the business quality against the current price and their own margin of safety requirements.

Bull Case

Viemed's 26% revenue growth trajectory could accelerate as it captures additional market share in the healthcare sector. With $16 million in annual free cash flow (4.3% yield), management has ample capital for buybacks, dividends, or accretive acquisitions.

Bear Case

Macro headwinds or sector-specific disruption could pressure margins, particularly if competitive intensity increases in the healthcare space. Regulatory changes, input cost inflation, or demand normalization represent underappreciated risks that could materially impact forward estimates.

Data from SEC filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer